Neurophth Biotechnology Ltd., a genetic medicines company, has raised $61.9 million in Series B financing. Guofang Capital and InnoVision Capital led the round.
Source: Press Release
Neurophth Biotechnology picks up $61.9m Series B
Neurophth Biotechnology Ltd., a genetic medicines company, has raised $61.9 million in Series B financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: